Captopril

The main ingredients of this product are: Captopril

1. Hypertension; 2. Heart failure.

It depends on the condition or individual differences. This product should be taken under the guidance or supervision of a physician. The dosage must follow the principle of individualization and be adjusted according to the therapeutic effect. 1. Common dosage for adults: (1) For hypertension, take 12.5 mg orally once, 2-3 times a day. Increase to 50 mg 2-3 times a day within 1-2 weeks as needed. If the therapeutic effect is still unsatisfactory, other antihypertensive drugs can be added. (2) For heart failure, start with 12.5 mg orally once, 2-3 times a day. If necessary, gradually increase to 50 mg 2-3 times a day. If further increase is needed, observe the therapeutic effect for 2 weeks before considering it. For patients who have recently taken a large amount of diuretics and are in hyponatremia/hypovolemia but have normal or low blood pressure, the initial dose should be 6.25 mg 3 times a day, and then gradually increase to the common dose through testing. 2. Common dosage for children

1. The more common ones are: (1) Rash, which may be accompanied by itching and fever. It often occurs within 4 weeks of treatment and is maculopapular or urticaria. It disappears after reducing the dose, stopping the drug or taking antihistamines. 7%-10% are accompanied by eosinophilia or positive antinuclear antibodies. (2) Palpitations, tachycardia, chest pain. (3) Cough. (4) Dilated taste. 2. Less common ones are: (1) Proteinuria, which often occurs within 8 months of the start of treatment. One quarter of them will develop nephrotic syndrome, but proteinuria will gradually decrease within 6 months and the course of treatment will not be affected. (2) Dizziness, headache, and syncope. It is caused by hypotension, especially when there is a lack of sodium or blood volume. (3) Angioedema, which occurs on the face and limbs, and can also cause angioedema of the tongue, glottis or larynx. Be vigilant. (4) Rapid heart rate and

Patients who are allergic to this product or other angiotensin-converting enzyme inhibitors are contraindicated.

Keep in a light-proof and sealed place

Zhejiang Ruixin Pharmaceutical Co., Ltd.

• Founded in:

  2002-01-08

• Address:

  Development Road, Tianning Industrial Zone, Liandu District, Lishui City, Zhejiang Province

• Tax NO.:

  91330000735259021T

• Registered Funds:

  50 million yuan

• Website:

  Log in to view

• Email:

  Log in to view